Loading...
Swedish Orphan Biovitrum Community
OM:SOBI Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 15 Fair Values set on narratives written by author
Community Investing Ideas
SOBI: Upgraded Recommendation Signals Confidence Amid Balanced Risks And Advancing Pipeline
Key Takeaways Successful Altuvoct launch in Europe and expanding regulatory approvals for Aspaveli and Gamifant could significantly boost revenue through market share growth and new entries. Strategic operational efficiency, cost management, and increased Beyfortus royalties are expected to enhance margins and stabilize earnings.Read more
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
SEK 351.09
6.2% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
9.93% p.a.
Profit Margin
19.98%
Future PE
19.21x
Share price in 2028
SEK 407.75